Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the online publication of safety data from ...

Ataxia-telangiectasia (A-T) remains an incurable disease with limited treatment options. The progression of clinical trials is hindered by the lack of diagnostic and disease progression biomarkers for ...

The event brought together 300 researchers, clinicians, industry leaders, and entrepreneurs to highlight their work.

Babson Diagnostics, a science-first healthcare technology company, today announced that BetterWaytm blood testing is a finalist for the 2025 South by Southwest (SXSW) Innovation Awards in the Health & ...

PDA today released the names of its 2025 Board of Directors following fall elections by the membership. The officers and directors represent pharmaceutical/biopharmaceutical businesses of all sizes ...

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by ...

Rakovina Therapeutics Inc., a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, announced the successful achievement of a shortlist ...

The biological control of gene expression requires the temporal and spatial integration of dynamic processes. These include nuclear import, intranuclear targeting and chromatin remodelling that ...